Long-Term Response Durability of Infliximab for Pediatric Inflammatory Bowel Disease in Japan: A Single Center Experience
The long-term durability of IFX in Japanese pediatric patients with IBD was inadequate in UC compared with CD. Serious adverse events in 3.6% of patients required discontinuation.
Authors
- Naoya Tsumura (ORCID: https://orcid.org/0000-0002-0793-2121)
- Ryosuke Yasuda
- Hidetoshi Takedatsu (ORCID: https://orcid.org/0000-0002-0318-0129)
- Tatsuki Mizuochi (ORCID: https://orcid.org/0000-0002-2943-7068)
- Shinichiro Yoshioka (ORCID: https://orcid.org/0000-0001-9068-1783)
- Ken Kato
Institutions
- Kurume University (JP)
Publication Details
- Journal
- Pediatric Gastroenterology Hepatology & Nutrition
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5223/pghn.2025.28.3.166
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82